A$0.18 BRN.AX BrainChip Holdings (ASX) pre-market 09 Jan 2026: A$0.25 target
BRN.AX stock trades at A$0.18 in pre-market trade on 09 Jan 2026. That price sits near the 50-day average of A$0.18 and well below the 52-week high of A$0.42. Volume is light today at 1,609,468 shares versus a 30-day average of 10,084,825. Investors watching BrainChip Holdings Ltd (BRN.AX) will focus on edge-AI demand, upcoming earnings on 04 Mar 2026, and how the Akida neuromorphic processor commercial rollout lifts revenue and margins.
BRN.AX stock: price, liquidity and short-term drivers
The immediate fact is the market price: A$0.18 per share with a market capitalisation of A$424,983,875.00. Today’s range is A$0.18 high and A$0.18 open, with a year low of A$0.16 and year high of A$0.42.
Liquidity remains uneven. Average daily volume is 10,084,825.00 shares, so current trade volume of 1,609,468.00 is about 0.29 times average. That low relative volume can magnify price moves on news or block trades.
BRN.AX stock: fundamentals and valuation metrics
BrainChip Holdings Ltd (BRN.AX) shows stretched valuation ratios because revenue is still small relative to market cap. Price to sales is 217.29, price to book is 16.51, and trailing EPS is -0.02 giving a negative PE of -9.00. Current ratio of 5.18 and cash per share A$0.01 point to short-term liquidity cover.
Financial growth improved in FY2024 with revenue growth of 71.55% year over year, but margins remain negative: operating margin -17.03% and net margin -16.94%. R&D spend is high at 5.23 times revenue to support Akida product development.
BRN.AX stock: technicals and momentum signals
Technical indicators show a neutral to mild positive bias. RSI at 55.38 and Stochastic %K at 100.00 suggest recent buying interest without a strong trend. ADX is 13.22, signalling no trend.
Volatility tools place Bollinger Bands at Upper A$0.19 / Middle A$0.17 / Lower A$0.15, and ATR at A$0.01. These numbers imply tight intraday swings but potential for burst moves if volume returns.
BRN.AX stock: Meyka AI grade and model forecast
Meyka AI rates BRN.AX with a score out of 100: 68.75 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts.
Meyka AI’s forecast model projects a yearly price of A$0.23 and a quarterly target of A$0.25. Versus the current A$0.18, the yearly forecast implies +28.13% upside and the quarterly target implies +38.89% upside. Forecasts are model-based projections and not guarantees.
BRN.AX stock: risks, opportunities and sector context
Opportunity: BrainChip’s Akida neuromorphic chips address low-power edge-AI demand in automotive, security and IoT. Continued design wins could lift revenue and narrow the valuation gap with peers in the technology sector.
Risk: Revenue remains small versus market cap and margins are negative. Price-to-sales of 217.29 and thin daily liquidity raise volatility risk. For context, the ASX technology sector average PE is about 40.91, underscoring BrainChip’s early-stage status.
Final Thoughts
Key takeaways on BRN.AX stock: BrainChip trades at A$0.18 with high volatility potential and light volume. Fundamentals show improving revenue growth but negative margins and stretched valuation ratios: price/sales 217.29 and price/book 16.51. Meyka AI’s forecast model projects a yearly price of A$0.23 (implied +28.13%) and a nearer-term quarterly target of A$0.25 (implied +38.89%). Those targets assume successful Akida commercial adoption and steadier volumes. Traders should weigh upside from product traction against downside from low liquidity and negative earnings. We use Meyka AI as an AI-powered market analysis platform to set model-driven targets; forecasts are projections and not guarantees. Monitor upcoming earnings on 04 Mar 2026, R&D milestones and any material design-win announcements as the next catalysts for BRN.AX stock.
FAQs
What is the current price of BRN.AX stock?
BRN.AX stock trades at A$0.18 pre-market on 09 Jan 2026, with today’s volume at 1,609,468 shares and a market cap of A$424,983,875.00. Price sits below the 52-week high of A$0.42.
What forecast does Meyka AI give for BRN.AX stock?
Meyka AI’s forecast model projects a yearly price of A$0.23 and a quarterly target of A$0.25 for BRN.AX stock. The yearly projection implies about +28.13% upside from today’s A$0.18. Forecasts are model-based and not guarantees.
What are the main risks for BRN.AX stock?
Primary risks include thin liquidity, negative earnings (EPS -0.02), stretched valuation ratios (price/sales 217.29) and execution risk in converting Akida design wins into repeatable revenue. These raise downside volatility for BRN.AX stock.
When is BrainChip’s next earnings announcement?
BrainChip’s next scheduled earnings announcement is on 04 Mar 2026. That report will be important for revenue, guidance and timing of any commercial rollouts for the Akida platform, and it can move BRN.AX stock materially.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
